Obesity experts say that roughly 20% of patients — as many as 1 in 5 — may not see robust results with the new medications.

Novo Nordisk has launched its weight-loss drug Wegovy in China — but for a tiny fraction of what it's charging customers in ...

Weight loss drugs like Ozempic and Wegovy have gained popularity for their ability to help users shed pounds, but medical ...

We recently published a list of 8 Most Promising Healthcare Stocks According to Hedge Funds. In this article, we are going to ...

She said weight-loss drugs such as semaglutide, sold as Ozempic and Wegovy, and tirzepatide, sold as Mounjaro, were safe if ...